TBPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Theravance Biopharma Inc

Watchlist Manager

Watchlist

Price: 17.04 USD 0.06% Market Closed

Market Cap: $883.2m

	Theravance Biopharma Inc NASDAQ:TBPH	KY
	Decision Diagnostics Corp OTC:DECN	US
R	RS PCL SET:RS	TH
C	Consolidated Edison Inc F:EDC	US
	ProPetro Holding Corp NYSE:PUMP	US
	M&T Bank Corp NYSE:MTB	US
	Telkom Indonesia (Persero) Tbk PT IDX:TLKM	ID
C	China Life Insurance Co Ltd XMUN:CHL	CN
E	EPIC Suisse AG SIX:EPIC	CH
S	Steyr Motors AG DUS:4X0	AT
	Trek Metals Ltd ASX:TKM	BM
	Riber SA PAR:ALRIB	FR

Profitability Summary

Theravance Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-52%

Operating Margin is Increasing

-133% > 9%

Exceptional Net Margin

52%

Negative 3Y Average Net Margin

-25%

Declining Net Margin

1 696% > 52%

Exceptional Free Cash Flow Margin

52%

Strong 3Y Average Free Cash Flow Margin

64%

Free Cash Flow Margin is Increasing

-336% > 52%

Positive ROE

21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-14%

ROIC is Increasing

-27% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.